[Pharmacokinetic characteristics and antimicrobial spectrum of teicoplanin]
- PMID: 12481490
[Pharmacokinetic characteristics and antimicrobial spectrum of teicoplanin]
Abstract
Teicoplanin is a glycopeptide antibiotic with similar spectrum to vancomycin. Its long half-life permits administration in a single daily dose. The adverse effects of teicoplanin are less frequent than those of vancomycin. Rash and local intolerance are the most frequent. Staphylococcus aureus, coagulase-negative staphylococci and Enterococcus sp. are susceptible to teicoplanin. Clinical data have shown teicoplanin to be less nephrotoxic than vancomycin when combined with amino glycosides. Teicoplanin, alone or in combination with additional antibacterial drugs, has proven to be effective in the treatment of several Gram-positive infections, such as sepsis, bone and joint infections, endocarditis and skin and soft tissue infections. Clinical efficacy was obtained in more than 90% of the patients treated. Similar data have been reported in adults, children and elderly patients. Due to its easy administration and dosage, teicoplanin is a treatment of choice for outpatient parenteral therapies.
Similar articles
-
[Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms].Medicina (B Aires). 2002;62 Suppl 2:48-51. Medicina (B Aires). 2002. PMID: 12481489 Spanish.
-
[New therapeutic strategies with teicoplanin].Medicina (B Aires). 2002;62 Suppl 2:25-9. Medicina (B Aires). 2002. PMID: 12481485 Review. Spanish.
-
Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.Clin Ther. 2009 Sep;31(9):1977-86. doi: 10.1016/j.clinthera.2009.09.010. Clin Ther. 2009. PMID: 19843487
-
Dalbavancin, a long-acting lipoglycopeptide for the treatment of multidrug-resistant Gram-positive bacteria.Expert Rev Anti Infect Ther. 2007 Aug;5(4):557-71. doi: 10.1586/14787210.5.4.557. Expert Rev Anti Infect Ther. 2007. PMID: 17678421 Review.
-
Teicoplanin: an investigational glycopeptide antibiotic.Clin Pharm. 1988 Sep;7(9):647-58. Clin Pharm. 1988. PMID: 2977108 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical